Short-term human studies have generally found NMN to be well tolerated, but that does not mean every symptom reported after taking NMN is impossible—or that long-term safety has been established.
Controlled human trials have tested oral NMN at amounts ranging from a single 100–500 mg dose to repeated daily amounts of 250 mg, 300–900 mg, 1,250 mg, and—in studies of a pharmaceutical-grade microcrystalline β-NMN formulation—up to 2,000 mg per day for short periods.12345
Across these studies, serious treatment-related adverse events have not emerged as a consistent signal. However, most trials were small, lasted days to a few months, and enrolled selected populations. They cannot rule out rare adverse effects, delayed effects, risks from years of use, medication interactions, or risks in people with significant medical conditions.
That distinction matters because many searches for NMN side effects involve symptoms such as fatigue, sleepiness, brain fog, bloating, diarrhea, constipation, headaches, anxiety, or simply “feeling weird.” Some of these symptoms have appeared during trials, but controlled studies do not show that most are predictable or common effects caused by NMN itself.
NMN Side Effects at a Glance
| Concern | What human evidence currently shows |
|---|---|
| Overall short-term tolerability | Generally good in the human trials published so far, with no consistent increase in serious treatment-related adverse events. |
| Digestive symptoms | Abdominal discomfort and other gastrointestinal symptoms have occurred in trials, but they have not formed a consistent dose-related NMN safety signal. |
| Headache | Not established as a predictable NMN adverse effect. In one 12-week placebo-controlled trial, headache occurred in placebo participants but not in the NMN group. |
| Fatigue or sleepiness | Frequently searched and reported anecdotally, but controlled studies have not established fatigue or sleepiness as a routine treatment-related effect. |
| Brain fog, anxiety, irritability or “feeling weird” | Not established as predictable NMN adverse effects in controlled trials. |
| Liver toxicity | No clear liver-enzyme toxicity signal has appeared in short-term trials, but chronic liver-disease and long-term high-dose data remain limited. |
| Kidney toxicity | No consistent kidney-injury signal has emerged in short trials. This does not establish long-term safety for chronic kidney disease. |
| Cancer | No human trial has shown that NMN causes or prevents cancer. Recent preclinical cancer findings justify extra caution during active cancer treatment. |
| Blood pressure | No consistent signal that NMN raises blood pressure has been established in human trials. |
| Blood thinning | NMN has not been established as a blood thinner in human studies. |
| Withdrawal | No recognized NMN withdrawal syndrome has been established. |
| Long-term daily use | Uncertain. Most controlled studies are short, and the longest published trials involve relatively small groups. |
Is NMN Safe?
The most accurate answer is: NMN has shown generally good short-term tolerability in human trials, but long-term safety is not yet well established.
Several studies help define what “short-term tolerability” currently means.
Single-Dose Study: 100–500 mg
In the first published human safety study, 10 healthy men received single oral doses of 100 mg, 250 mg, and 500 mg of NMN. Researchers did not observe significant clinical symptoms or meaningful changes in heart rate, blood pressure, oxygen saturation, body temperature, ophthalmic measures, or sleep-quality scores.1
Some laboratory values changed within normal physiological ranges, but the study was extremely small and evaluated only acute exposure.
250 mg Daily for 12 Weeks
In a placebo-controlled study of 30 healthy adults, 15 participants received 250 mg of NMN daily for 12 weeks.2
Any adverse event was reported by:
- 7 of 15 participants in the placebo group; and
- 8 of 15 participants in the NMN group.
No serious adverse events occurred in either group.
Researchers judged one event in the NMN group as related to the intervention: abdominal pain beginning shortly after NMN intake and resolving spontaneously within about 30 minutes. One placebo participant discontinued because of gastrointestinal symptoms.
Liver enzymes, kidney-function measurements, electrolytes, and blood counts showed no significant differences between NMN and placebo.
300, 600, or 900 mg Daily for 60 Days
A randomized trial assigned 80 healthy middle-aged adults to placebo or 300 mg, 600 mg, or 900 mg of NMN daily for 60 days.3
Nine adverse-event episodes occurred in seven participants:
- six events in placebo participants;
- three events in participants taking 300 mg;
- no adverse events in the 600 mg group; and
- no adverse events in the 900 mg group.
Investigators judged all events mild or moderate and none related to NMN treatment.
The study also measured liver enzymes, creatinine, blood urea nitrogen, estimated kidney filtration, blood counts, clotting measures, electrolytes, lipids, glucose, and urinalysis. No clinically meaningful safety abnormalities were reported.
1,250 mg Daily for Four Weeks
A randomized, double-blind safety study gave 1,250 mg of β-NMN once daily for up to four weeks to healthy men and women aged 20 to 65.4
The study did not find changes exceeding expected physiological variation in its anthropometric, blood, biochemical, urine, or body-composition measurements, and no severe adverse events were reported.
This is useful high-dose short-term evidence. It is not evidence that taking 1,250 mg indefinitely is safe or beneficial.
Microcrystalline β-NMN at Up to 2,000 mg per Day
Short studies of the pharmaceutical-grade microcrystalline β-NMN formulation MIB-626 have also tested 1,000 mg once or twice daily.56
In a 28-day trial involving overweight or obese middle-aged and older adults, adverse events were similar between the NMN and placebo groups. In another short trial involving hospitalized adults with COVID-19 and acute kidney injury, 1,000 mg twice daily increased blood NAD+ without worsening measured kidney-injury markers relative to placebo.6
These studies involved a particular microcrystalline investigational formulation and specific clinical populations. Their findings should not automatically be transferred to every retail NMN supplement.
What the Overall Safety Literature Shows
A 2026 systematic review and meta-analysis pooled randomized controlled trials of oral NMN or related NMN preparations.7
Across the included safety analyses, researchers did not find a significant increase in:
- overall adverse events;
- serious adverse events;
- withdrawals because of adverse events;
- gastrointestinal adverse events;
- nervous-system adverse events;
- skin or allergic adverse events;
- ALT or AST liver-enzyme levels.
The authors also emphasized the central limitation: the evidence base is still too small and short to exclude rare, delayed, long-term, high-dose, or population-specific risks.
What Side Effects Have Actually Been Reported?
A symptom that occurs while someone is taking NMN is not automatically caused by NMN.
Clinical trials separate several different concepts:
- adverse event: something happened during the study;
- treatment-related adverse event: investigators judged the event likely related to the intervention;
- laboratory change: a measured value changed;
- serious adverse event: an event meeting a formal seriousness definition.
This distinction is important because some trials recorded symptoms such as gastrointestinal discomfort, fatigue, skin symptoms, fever, or other events in both placebo and NMN groups.
The published studies do not support turning every online complaint into a standard list of “NMN side effects.”
Can NMN Cause Bloating, Stomach Pain, Diarrhea, or Constipation?
Digestive symptoms are plausible with almost any oral supplement, but current human evidence does not show that NMN consistently causes bloating, diarrhea, constipation, or stomach pain.
The clearest treatment-related gastrointestinal event in a controlled NMN trial involved one participant taking 250 mg daily who experienced short-lived abdominal pain soon after ingestion.2
That same trial recorded gastrointestinal symptoms in both groups:
- 3 of 15 NMN participants; and
- 2 of 15 placebo participants.
The category included abdominal pain, abdominal discomfort, diarrhea, hunger, abdominal distension, belching, or gas.
This does not establish that NMN was the cause of every recorded digestive symptom.
Can NMN Cause Bloating?
Bloating has not emerged as a consistent treatment-related effect in controlled NMN trials.
If bloating begins after starting a product, possible contributors can include:
- the NMN itself;
- capsule or tablet excipients;
- sweeteners or flavoring in powders, liquids, or gummies;
- other supplements taken at the same time;
- dietary changes;
- unrelated gastrointestinal conditions.
Can NMN Cause Diarrhea?
Diarrhea has been recorded among gastrointestinal events in human research, but there is not enough evidence to classify it as a common or predictable NMN side effect.
Can NMN Cause Constipation?
Constipation has not been established as a characteristic NMN adverse effect in controlled trials.
Should NMN Be Taken on an Empty Stomach?
There is no human safety evidence showing that everyone should take NMN on an empty stomach—or that taking it with food reliably prevents side effects.
Human NMN trials have used different administration instructions. Follow the directions for the specific product you use.
For timing questions, see our guide to the best time to take NMN.
Can NMN Make You Tired or Sleepy?
Fatigue and sleepiness are real search concerns, but they are not established predictable NMN side effects.
One 12-week trial of 250 mg NMN recorded fever, joint pain, or fatigue more often in the NMN group than placebo, but investigators noted that COVID-19 vaccination was suspected as the cause of these events.2
Another randomized study involving 108 older adults specifically evaluated sleep quality, fatigue, and physical performance while participants took 250 mg of NMN in the morning or afternoon.8
That trial did not establish fatigue or daytime sleepiness as a routine adverse effect of NMN. Some sleep- and drowsiness-related outcomes were investigated as possible benefits rather than safety problems.
If you feel unusually tired after starting NMN, that symptom alone cannot tell you whether:
- NMN caused it;
- the amount is inappropriate for you;
- another supplement or medication contributed;
- your sleep changed;
- caffeine intake changed;
- you are developing an unrelated illness.
Persistent or significant fatigue deserves evaluation rather than an assumption that NAD+ is “too high” or “too low.”
Can NMN Cause Brain Fog or Make You Feel Weird?
Brain fog, feeling strange, irritability, anxiety, and similar subjective complaints appear in searches and online discussions, but controlled human trials have not established these as predictable NMN adverse effects.
There is also no validated symptom pattern that tells you NMN is “adjusting your NAD+ levels.”
If a new cognitive or mood symptom begins soon after starting a supplement, useful questions include:
- Did you start more than one supplement at the same time?
- Did your sleep change?
- Did caffeine, alcohol, or medication use change?
- Did you increase the amount recently?
- Does the product contain other active ingredients?
- Does the symptom improve after stopping the product?
Severe confusion, weakness, fainting, neurological symptoms, or rapidly worsening mental-status changes require medical assessment rather than supplement troubleshooting.
Can NMN Cause Headaches?
Headache has not emerged as a consistent NMN treatment-related effect.
In the 250 mg, 12-week placebo-controlled trial, two placebo participants reported headache while none of the NMN participants did.2
That does not prove NMN can never contribute to headache. It does show why headache should not be presented as an established common NMN side effect based only on anecdotal reports.
Can NMN Cause Anxiety or Irritability?
Current controlled human evidence does not establish anxiety, irritability, anger, or “rage” as characteristic NMN side effects.
These symptoms may occur while someone is taking NMN, but timing alone cannot prove causality.
Do not assume that irritability means your body is “adjusting to higher NAD+.” Human trials have not validated that explanation.
Does NMN Affect Sleep?
NMN has not been shown to predictably cause insomnia or sleepiness.
NAD+ metabolism interacts with circadian biology, but a mechanism is not the same thing as a demonstrated clinical side effect.
Human studies evaluating morning versus later-day NMN have not established one universal safety rule requiring morning dosing.
If sleep changes after starting NMN, consider the full routine rather than assuming NMN is the only cause.
For a full timing discussion, see when to take NMN.
Is NMN Toxic to the Liver?
Short-term human studies have not shown a clear liver-toxicity signal from NMN.
Several trials measured liver-related blood chemistry while participants took NMN:
- 250 mg daily for 12 weeks showed no significant difference in liver enzymes versus placebo;2
- 300–900 mg daily for 60 days did not produce clinically meaningful liver-test abnormalities;3
- 1,250 mg daily for four weeks did not produce changes outside expected physiological variation in biochemical testing.4
The 2026 meta-analysis also found no significant elevation in ALT or AST across the randomized trials included in its safety analysis.7
That does not prove NMN is incapable of affecting the liver under every condition.
Important gaps remain:
- very long-term use;
- rare idiosyncratic reactions;
- people with advanced liver disease;
- interactions with hepatotoxic medications;
- multi-ingredient supplements where NMN is only one component.
If you have liver disease or abnormal liver tests, discuss NMN with the clinician managing that condition rather than relying on safety findings from healthy volunteers.
Is NMN Bad for the Kidneys?
Short-term human data have not shown a consistent kidney-toxicity signal.
The 250 mg and 300–900 mg trials monitored measures such as serum creatinine, blood urea nitrogen, estimated filtration, urinalysis, and related laboratory markers without identifying a clear treatment-related renal safety problem.23
A separate randomized study administered 1,000 mg of microcrystalline β-NMN twice daily for 14 days to hospitalized adults with COVID-19 and acute kidney injury.6
Blood NAD+ increased, while changes in serum creatinine, cystatin C, and measured acute-kidney-injury markers did not differ significantly from placebo.
This is useful safety information, but it does not establish that every NMN supplement is appropriate for someone with chronic kidney disease or kidney failure.
Does NMN Cause Cancer?
No human trial has shown that NMN supplementation causes cancer.
It is equally important not to claim that NMN prevents cancer because NAD+ participates in DNA repair.
NAD+ biology is relevant to both normal cells and cancer cells. Cancer cells can depend on NAD+ metabolism for energy production, stress responses, DNA repair, and survival. That makes the cancer question biologically complex.
What Human Studies Tell Us
The existing human NMN trials were generally too small and too short to evaluate:
- new cancer incidence;
- cancer recurrence;
- tumor progression;
- long-term cancer mortality.
Therefore, current human evidence cannot establish that NMN either increases or reduces cancer risk.
Why Active Cancer Requires More Caution
A 2026 preclinical study examined NMN and other vitamin B3-derived NAD+ precursors in pancreatic cancer cell lines and mouse models.9
In those experimental systems, NMN increased cancer-cell survival during treatment with several chemotherapy drugs and promoted chemotherapy resistance in mouse models.
This is preclinical evidence. It does not prove the same effect occurs in people taking NMN supplements.
However, it is directly relevant to the safety question for someone with active cancer or undergoing chemotherapy.
If you have cancer or are receiving chemotherapy, immunotherapy, radiation, or another cancer treatment, do not add an NAD+-boosting supplement without discussing it with your oncology team.
Can NMN Raise Blood Pressure?
Human trials have not identified a consistent blood-pressure increase caused by NMN.
Some studies found no meaningful change, while a short MIB-626 study reported a decrease in diastolic blood pressure rather than an increase.5
That does not make NMN a blood-pressure treatment.
If you have hypertension or take blood-pressure medication, the relevant question is not whether NMN is “good” or “bad” for blood pressure in general, but whether it is appropriate alongside your medical treatment.
Does NMN Thin the Blood?
NMN has not been established as a blood thinner.
In the 60-day trial testing 300, 600, and 900 mg daily, researchers included prothrombin time and activated partial thromboplastin time among laboratory safety measurements and reported no clinically meaningful abnormalities.3
Interaction data with anticoagulant or antiplatelet medications remain limited.
If you take prescription blood thinners, do not assume that “no known blood-thinning effect” means there is no interaction risk.
Do Different NMN Forms Have Different Side Effects?
There is not enough human evidence to say that capsules, powder, liposomal NMN, tablets, or sublingual NMN have meaningfully different safety profiles because of the delivery format alone.
A symptom can also come from parts of a finished product other than NMN, including:
- capsule materials;
- binders and flow agents;
- flavors;
- sweeteners;
- phospholipids;
- other active ingredients.
Do not assume that:
- liposomal NMN causes fewer side effects because it absorbs better;
- powder causes more bloating;
- sublingual NMN bypasses the digestive tract enough to eliminate gastrointestinal effects;
- faster absorption automatically means better tolerability.
Those claims require finished-product comparative evidence.
Are There Side Effects From NMN + Resveratrol?
NMN and resveratrol are frequently combined in supplements, but controlled human evidence for the safety or superiority of the combination is much more limited than evidence for the ingredients studied separately.
If someone develops:
- headache;
- nausea;
- digestive discomfort;
- sleep changes;
- dizziness;
while taking a combination product, the symptom cannot automatically be assigned to NMN.
Resveratrol has its own pharmacology and interaction considerations.
For the combination evidence, see NMN and resveratrol.
Who Should Not Take NMN?
There is no universal list of absolute NMN contraindications established by large clinical trials, but several groups have important evidence gaps or reasons for extra caution.
Pregnant or Breastfeeding People
Human pregnancy and breastfeeding safety has not been established. Pregnancy and breastfeeding were exclusion criteria in NMN trials.
For a detailed review, see NMN during pregnancy.
Children and Adolescents
NMN has not been adequately studied as a long-term supplement in children or adolescents.
People With Active Cancer or Receiving Cancer Treatment
Human cancer-safety data are inadequate, and recent preclinical evidence raises a potential chemotherapy-interaction concern in pancreatic cancer models.9
Use should be reviewed with the oncology team.
People With Significant Liver or Kidney Disease
Most NMN studies were not designed to establish long-term supplement safety in people with advanced chronic liver or kidney disease.
Short-term safety findings from healthy adults should not automatically be generalized to these populations.
People Taking Prescription Medication
NMN has not been tested systematically with every medication class.
If you take prescription medication—especially several medications—have the full supplement list reviewed by a healthcare professional.
People Preparing for Surgery
There is no NMN-specific surgical interaction database robust enough to support a universal rule. Tell the surgical team about all supplements you use and follow their instructions about what to stop and when.
What Should You Avoid When Taking NMN?
There is no validated list of foods that everyone must avoid while taking NMN.
More useful precautions are:
- do not exceed the product directions simply because higher doses have appeared in short trials;
- do not assume that combining NMN, NR, NAD+, resveratrol, TMG, or other “longevity” supplements is automatically safer or more effective;
- do not use NMN during active cancer treatment without oncology review;
- do not use pregnancy or animal-fertility research as proof of pregnancy safety;
- do not ignore persistent symptoms because they are described online as a normal “adjustment.”
What Happens If You Take NMN Every Day?
Daily NMN dosing has been used in many human trials.
Examples include:
- 250 mg daily for 10–12 weeks;210
- 300–900 mg daily for 60 days;3
- 1,250 mg daily for four weeks;4
- 250 mg daily for up to 24 weeks in a small trial involving older men with diabetes and impaired physical function.11
These studies suggest that repeated daily use can be tolerated over the periods tested.
They do not answer what happens after:
- one year;
- five years;
- decades of supplementation;
- long-term use at high amounts;
- use alongside multiple medications or supplements.
There is no established evidence-based maximum duration for general NMN supplementation.
For study amounts and dosing limitations, see our NMN dosage guide.
Is NMN Safe Long Term?
Long-term safety remains uncertain.
This is not because human trials have identified a clear long-term toxicity signal. It is because most studies have not lasted long enough or included enough people to detect uncommon or delayed effects.
A supplement can look well tolerated over 8 or 12 weeks and still have unanswered questions about multi-year use.
Longer and larger safety studies are still needed.
What Should You Do If NMN Causes Symptoms?
If a symptom begins after starting NMN, first distinguish mild symptoms from symptoms that require urgent medical attention.
Stop and Seek Prompt Medical Care for Symptoms Such As:
- difficulty breathing;
- facial or throat swelling;
- fainting;
- severe or persistent abdominal pain;
- chest pain;
- new significant weakness;
- severe confusion or neurological symptoms;
- signs of a serious allergic reaction.
For Mild but Persistent Symptoms
Consider:
- stopping the new supplement;
- reviewing whether other supplements were started at the same time;
- checking the complete ingredient label;
- reviewing the amount taken;
- discussing persistent symptoms with a healthcare professional.
Do not increase the amount in an attempt to “push through” fatigue, brain fog, stomach symptoms, or sleep changes.
What Happens When You Stop Taking NMN?
No recognized NMN withdrawal syndrome has been established.
Human studies show that NAD+-related biomarkers can move back toward baseline after supplementation ends, but that does not prove that fatigue, brain fog, mood changes, or an “energy crash” after stopping are caused by NAD+ falling.
For the full discontinuation evidence, see what happens when you stop taking NMN.
Is the NMN Regulatory Controversy a Safety Warning?
Not necessarily.
Questions about whether NMN can be marketed as a dietary supplement, whether a retailer sells it, or how regulators classify it are different from the question of whether human trials show toxicity.
A regulatory dispute should not automatically be interpreted as proof that NMN is dangerous, just as legal availability does not prove that every dose or product is safe.
For current regulatory details, see our NMN regulatory-status guide.
Frequently Asked Questions
What are the negative side effects of NMN?
Human trials have not identified a consistent set of common treatment-related NMN side effects. Gastrointestinal symptoms have occurred, including one short-lived case of abdominal pain judged related to NMN in a 12-week study. Headache, fatigue, skin symptoms, and other events have also occurred during trials, but many appeared in placebo participants or were not judged related to NMN.
Is NMN toxic to the liver?
Short-term human trials have not shown a clear liver-toxicity signal, and pooled randomized-trial data have not shown significant ALT or AST elevations. Long-term safety and safety in people with serious liver disease remain less certain.
What happens if I take NMN every day?
Daily dosing has generally been tolerated during human trials lasting from several weeks to several months. Blood NAD+-related biomarkers often increase, but long-term multi-year safety and clinical benefits remain uncertain.
Who should avoid taking NMN?
Pregnant or breastfeeding people, children, people with active cancer or undergoing cancer treatment, and people with significant medical conditions or complex medication regimens should not treat the existing healthy-adult safety studies as proof that NMN is appropriate for them. Clinical guidance is warranted.
What should not be mixed with NMN?
There is no comprehensive, clinically validated list of prohibited NMN combinations. Interaction research is limited. The safest approach is to review NMN with a healthcare professional if you use prescription medications or combine several NAD+-related or “longevity” supplements.
Why do I feel weird when I take NMN?
There is no recognized NMN “adjustment syndrome.” Feeling unusual could reflect the supplement, another ingredient, another supplement, medication, sleep, caffeine, illness, or another unrelated factor. Persistent or significant symptoms should not be dismissed as a normal sign that NMN is working.
Can NMN make you tired?
Fatigue is not an established predictable NMN side effect. Controlled trials have not shown a consistent fatigue signal caused by NMN.
Does NMN make you sleepy?
Sleepiness has not been established as a routine treatment-related effect. Human trials examining NMN, fatigue, and sleep have produced mixed exploratory findings rather than evidence of predictable sedation.
Can NMN cause bloating?
Bloating can occur while using an oral supplement, but current controlled evidence does not establish it as a common NMN-specific adverse effect. Product excipients, other supplements, diet, and unrelated digestive conditions can also contribute.
Can NMN cause diarrhea?
Diarrhea has been recorded among gastrointestinal events in some studies, but evidence does not show that it is a common or predictable treatment-related NMN effect.
Can NMN cause constipation?
Constipation has not been established as a characteristic NMN adverse effect in controlled trials.
Can NMN cause headaches?
Headache has not emerged as a consistent NMN-related safety signal. In one placebo-controlled study, headaches occurred in placebo participants but not in the NMN group.
Does NMN cause high blood pressure?
Human studies have not shown a consistent increase in blood pressure caused by NMN. NMN should not be used as a treatment for high or low blood pressure.
Does NMN thin the blood?
NMN has not been established as a blood thinner. Human interaction data with anticoagulant or antiplatelet medicines are limited, so people using those medications should discuss NMN with their healthcare professional.
Does NMN cause cancer?
No human evidence shows that NMN supplementation causes cancer. Human trials are also too short to establish long-term cancer safety. A 2026 preclinical pancreatic-cancer study raised a chemotherapy-resistance concern in cells and mice, so people with active cancer or undergoing treatment should involve their oncology team before using NMN.
Do doctors recommend NMN?
There is no universal medical recommendation that healthy adults should take NMN for anti-aging or longevity. Whether supplementation is appropriate depends on the individual, the product, other medications, health conditions, and the goal of use.
Is NMN safe to take long term?
Long-term safety is not established. Most controlled human trials lasted weeks to a few months, so rare and delayed risks remain uncertain.
The Bottom Line
Human NMN trials published so far are reassuring about short-term tolerability, but they should not be interpreted as proof of unlimited long-term safety.
The evidence currently supports several conclusions:
- serious treatment-related adverse events have not emerged as a consistent signal in short trials;
- digestive symptoms can occur, but they are not consistently shown to be caused by NMN;
- fatigue, sleepiness, brain fog, headache, anxiety, and “feeling weird” are not established predictable NMN effects;
- short-term studies have not shown a clear liver- or kidney-toxicity signal;
- NMN has not been shown to cause or prevent cancer in humans;
- recent preclinical cancer research creates a reason for extra caution during active cancer treatment;
- there is no recognized withdrawal syndrome;
- long-term, rare, interaction-related, and high-risk-population safety remain incompletely understood.
If you are considering NMN, use the exact product directions rather than assuming that a larger amount is better. Review the full ingredient list, especially in combination products, and involve a healthcare professional if you take medication or have a significant medical condition.
For related evidence, see our NMN dosage guide, NMN benefits and human evidence, NMN timing guide, and complete NMN overview.
References
- Irie J, Inagaki E, Fujita M, et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal. 2020;67(2):153–160. PMID: 31685720. doi:10.1507/endocrj.EJ19-0313.
- Okabe K, Yaku K, Uchida Y, et al. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Frontiers in Nutrition. 2022;9:868640. PMID: 35479740. doi:10.3389/fnut.2022.868640.
- Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29–43. PMID: 36482258. doi:10.1007/s11357-022-00705-1.
- Fukamizu Y, Uchida Y, Shigekawa A, Sato T, Kosaka H, Sakurai T. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Scientific Reports. 2022;12:14442. PMID: 36002548. doi:10.1038/s41598-022-18272-y.
- Pencina KM, Valderrabano R, Wipper B, et al. Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study. Journal of Clinical Endocrinology & Metabolism. 2023;108(8):1968–1980. PMID: 36740954. doi:10.1210/clinem/dgad027.
- Pencina KM, Leaf DE, Valderrabano RJ, et al. Oral MIB-626 (β Nicotinamide Mononucleotide) Safely Raises Blood Nicotinamide Adenine Dinucleotide Levels in Hospitalized Patients With COVID-19 and Acute Kidney Injury: A Randomized Controlled Trial. FASEB BioAdvances. 2025;7(8):e70011. PMID: 40746868. doi:10.1096/fba.2025-00014.
- Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. Nutrients. 2026;18(14):2251. PMID: 42514320.
- Kim M, et al. Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study. Nutrients. 2022;14(4):755. PMID: 35215405.
- Nakazzi F, Zarei M, Lopes M, et al. Vitamin B3 derivatives support pancreatic cancer cell survival and chemotherapy resistance. Cancer Letters. 2026;645:218334. PMID: 41724424. doi:10.1016/j.canlet.2026.218334.
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. PMID: 33888596. doi:10.1126/science.abe9985.
- Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study. Geriatrics & Gerontology International. 2023. PMID: 36443648.









